We are happy to announce the launch of Alliance Aligned®, a monthly publication providing economics and policy research pertaining to health. We aim to provide readers with a single source of the latest health economic trends.

In this issue:

• Drug prices and health care spending have been at the forefront of many political debates across the world. In this issue, we present a novel method of estimating high-cost oncology prices in the US; and we summarize a supplemental insurance program in China.
• Using Cox proportional hazard models, we show that changes in oncology prices in the United States are related to 1) time since FDA approval, and 2) time since previous price change.
• Across the Pacific, we highlight a pharmaceutical firm's joint venture with a reinsurance company to offer supplemental insurance in order to boost high priced oncology sales.

Click here to view the issue.

Not receiving the publication? Subscribe now, and don't miss a single update!